Trademark: DISRUPTING DISEASE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
DISRUPTING DISEASE
Click here to search for trademarks similar to DISRUPTING DISEASE
Proof of use for DISRUPTING DISEASE
We do not have any records of a proof of use for DISRUPTING DISEASE at this moment.
Possible trademark infringements of DISRUPTING DISEASE
Basic Information about DISRUPTING DISEASE
- Serial Number
- 98609018
- Filing Date
- 19 Jun 2024
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of DISRUPTING DISEASE on the blockchain with WikiTrademarks.io.
- First use of DISRUPTING DISEASE anywhere
- DISRUPTING DISEASE was first used on 31 Mar 2022 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns DISRUPTING DISEASE?
1. Alnylam Pharmaceuticals, Inc. Cambridge MA
Correspondent
- Jennifer Kwon Womble Bond Dickinson (US) LLP
- 950 Third Avenue, Suite 2400
- New York, NY 10022
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io